Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice

Artemisinin (qinghaosu), a unique endoperoxide sesquiterpene lactone isolated from Artemisia annua L., is a very active antimalarial drug, including severe and cerebral malaria. However, its therapeutical efficacy is limited due to its scarce bioavailability. In this article, artemisinin-loaded conventional and polyethylene glycol (PEGylated) liposomes were proposed as carriers to increase biopharmaceutical properties of the drug. Encapsulation efficacy was determined by high-performance liquid chromatography/diode array detection/electrospray ionization–mass spectrometry, dimensional analysis was performed by dynamic light scattering, and morphology was performed by trasmission electron microscopy. After dialysis, both liposomal formulations showed an encapsulation efficacy of more than 70%; mean diameter of all the artemisinin-loaded vesicles was approximately 130–140 nm. The polydispersity index of the formulations ranged from 0.2 to 0.3 and resulted as suitable for intraperitoneal (i.p.) administration. Pharmacokinetic profile and the main pharmacokinetic parameters of the carriers were evaluated in healthy mice i.p. Free artemisinin was rapidly cleared from plasma and hardly detected 1 hour after administration. Conversely, both liposomal formulations showed much longer blood-circulation time than free artemisinin; artemisinin was still detectable after 3 and 24 hours of administration, respectively, for conventional and PEGylated liposomes. AUC0–24h values were increased by approximately 6 times in both of the liposomal formulations, in comparison with free artemisinin. A strong effect of formulation on the half-life of artemisinin was enhanced by more than 5-fold by the incorporation of PEG into liposomes. Liposomes loaded with artemisinin, especially the long-circulating vesicles, could really represent a new strategy for developing smart, well-tolerated, and efficacious therapeutic nanocarriers to treat tumors, but could also be very useful to treat parasitic disease.

[1]  Hyunjin Park,et al.  Study of artemisinin nanocapsules as anticancer drug delivery systems. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[2]  Chih-Hsien Chang,et al.  Evaluation of pharmacokinetics of 111In-labeled VNB-PEGylated liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse model. , 2009, Cancer biotherapy & radiopharmaceuticals.

[3]  A. Bilia,et al.  Simultaneous analysis of artemisinin and flavonoids of several extracts of Artemisia annua L. obtained from a commercial sample and a selected cultivar. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[4]  Narendra Singh,et al.  Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat. , 2006, Cancer letters.

[5]  T. Efferth,et al.  Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system. , 2005, Antiviral research.

[6]  Narendra Singh,et al.  Artemisinin induces apoptosis in human cancer cells. , 2004, Anticancer research.

[7]  P. Duffy,et al.  Drug combinations for malaria: time to ACT? , 2004, The Lancet.

[8]  M. Gabriëls,et al.  Physical and chemical evaluation of liposomes, containing artesunate. , 2003, Journal of pharmaceutical and biomedical analysis.

[9]  K. Yuen,et al.  Inclusion Complexation of Artemisinin with α-, β-, and γ-Cyclodextrins , 2003 .

[10]  M. Detaevernier,et al.  Preparation of beta-artemether liposomes, their HPLC-UV evaluation and relevance for clearing recrudescent parasitaemia in Plasmodium chabaudi malaria-infected mice. , 2002, Journal of pharmaceutical and biomedical analysis.

[11]  M. Tanner,et al.  The potential of artemether for the control of schistosomiasis. , 2001, International journal for parasitology.

[12]  B. Lell,et al.  Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study. , 2001, The Journal of infectious diseases.

[13]  N. Singh,et al.  Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. , 2001, Life sciences.

[14]  K. Yuen,et al.  Improved oral bioavailability of artemisinin through inclusion complexation with β- and γ-cyclodextrins , 2001 .

[15]  W Richter,et al.  Freeze-fracture studies on lipids and membranes. , 2001, Micron.

[16]  R. Ho,et al.  Trends and developments in liposome drug delivery systems. , 2001, Journal of pharmaceutical sciences.

[17]  T. Andrews,et al.  Evaluation of [99mTc] liposomes as lymphoscintigraphic agents: Comparison with [99mTc] sulfur colloid and [99mTc] human serum albumin , 2001 .

[18]  T. Efferth,et al.  The anti-malarial artesunate is also active against cancer. , 2001, International journal of oncology.

[19]  S. Hirota,et al.  Intraperitoneal administration of doxorubicin encapsulating liposomes against peritoneal dissemination. , 2000, Toxicology letters.

[20]  P. Quinn,et al.  Hydration of DMPC and DPPC at 4°C produces a novel subgel phase with convex–concave bilayer curvatures , 2000 .

[21]  S. Weinkauf,et al.  Ultrastructural characterization of peptide-induced membrane fusion and peptide self-assembly in the lipid bilayer. , 1999, Biophysical journal.

[22]  A. Ulrich,et al.  Morphological transitions of brain sphingomyelin are determined by the hydration protocol: ripples re-arrange in plane, and sponge-like networks disintegrate into small vesicles. , 1999, Chemistry and physics of lipids.

[23]  T. Eggelte,et al.  Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. , 1999, Trends in pharmacological sciences.

[24]  A. Ulrich,et al.  Minimal radius of curvature of lipid bilayers in the gel phase state corresponds to the dimension of biomembrane structures "caveolae". , 1998, Journal of structural biology.

[25]  M. Al-Meshal,et al.  In vivo evaluation of arteether liposomes , 1998 .

[26]  W. Ballou,et al.  Malaria in 1998: advances in diagnosis, drugs and vaccine development , 1998, Current opinion in infectious diseases.

[27]  G. Storm,et al.  Lymphatic Uptake and Biodistribution of Liposomes After Subcutaneous Injection: III. Influence of Surface Modification with Poly(ethyleneglycol) , 1997, Pharmaceutical Research.

[28]  D. Crommelin,et al.  Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose. , 1997, Biochimica et biophysica acta.

[29]  D. Alberts,et al.  Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. , 1996, The New England journal of medicine.

[30]  N. Singh,et al.  Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. , 1995, Cancer letters.

[31]  J. Zuidema,et al.  Formulation and pharmacokinetics of artemisinin and its derivatives , 1991 .

[32]  D. L. Klayman,et al.  Qinghaosu (artemisinin): an antimalarial drug from China. , 1985, Science.

[33]  D. L. Klayman,et al.  Qinghaosu (artemisinin): an antimalarial drug from China , 1985 .

[34]  G. Gregoriadis,et al.  The effect of lipid composition of small unilamellar liposomes containing melphalan and vincristine on drug clearance after injection into mice. , 1983, Biochemical pharmacology.

[35]  K. D. Hartman,et al.  Lymphatic absorption and tissue disposition of liposome-entrapped [14C]adriamycin following intraperitoneal administration to rats. , 1981, Cancer research.

[36]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.

[37]  E. Schoffeniels,et al.  An isolated single electroplax preparation. I. New data on the effect of acetylcholine and related compounds. , 1957, Biochimica et biophysica acta.

[38]  P. Quinn,et al.  Hydration of DMPC and DPPC at 4 degrees C produces a novel subgel phase with convex-concave bilayer curvatures. , 2000, Chemistry and physics of lipids.

[39]  S. Meshnick.  Artemisinin antimalarials: mechanisms of action and resistance. , 1998, Medecine tropicale : revue du Corps de sante colonial.

[40]  S. Hirota,et al.  Effects of administered route on tissue distribution and antitumor activity of polyethyleneglycol-coated liposomes containing adriamycin. , 1997, Cancer letters.

[41]  Dexi Liu,et al.  Size Homogeneity of a Liposome Preparation is Crucial for Liposome Biodistribution in Vivo , 1992 .

[42]  S. Sieber,et al.  Comparison of lymphatic uptake, metabolism, excretion, and biodistribution of free and liposome-entrapped [14C]cytosine beta-D-arabinofuranoside following intraperitoneal administration to rats. , 1982, Drug metabolism and disposition: the biological fate of chemicals.